Predictive Oncology Price to Sales Ratio 2010-2024 | POAI
Historical PS ratio values for Predictive Oncology (POAI) over the last 10 years. The current P/S ratio for Predictive Oncology as of May 09, 2025 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Predictive Oncology P/S Ratio Historical Data |
| Date |
Stock Price |
TTM Sales per Share |
Price to Sales Ratio |
| 2025-05-09 |
1.11 |
|
3.43 |
| 2024-12-31 |
0.82 |
$0.32 |
2.54 |
| 2024-09-30 |
0.79 |
$0.27 |
2.90 |
| 2024-06-30 |
1.04 |
$0.39 |
2.69 |
| 2024-03-31 |
2.55 |
$0.45 |
5.68 |
| 2023-12-31 |
3.29 |
$0.41 |
8.10 |
| 2023-09-30 |
3.20 |
$0.45 |
7.12 |
| 2023-06-30 |
4.86 |
$0.40 |
12.21 |
| 2023-03-31 |
6.54 |
$0.38 |
17.26 |
| 2022-12-31 |
6.14 |
$0.41 |
14.83 |
| 2022-09-30 |
7.20 |
$0.49 |
14.72 |
| 2022-06-30 |
8.20 |
$0.47 |
17.50 |
| 2022-03-31 |
19.54 |
$0.50 |
39.01 |
| 2021-12-31 |
19.04 |
$0.56 |
34.07 |
| 2021-09-30 |
26.60 |
$0.88 |
30.33 |
| 2021-06-30 |
26.20 |
$1.42 |
18.44 |
| 2021-03-31 |
24.20 |
$1.66 |
14.61 |
| 2020-12-31 |
14.64 |
$2.72 |
5.39 |
| 2020-09-30 |
16.28 |
$4.65 |
3.50 |
| 2020-06-30 |
32.80 |
$7.33 |
4.48 |
| 2020-03-31 |
31.50 |
$7.91 |
3.98 |
| 2019-12-31 |
52.20 |
$9.94 |
5.25 |
| 2019-09-30 |
101.00 |
$12.38 |
8.16 |
| 2019-06-30 |
149.60 |
$14.03 |
10.66 |
| 2019-03-31 |
150.00 |
$19.12 |
7.85 |
| 2018-12-31 |
123.80 |
$23.11 |
5.36 |
| 2018-09-30 |
212.00 |
$25.17 |
8.42 |
| 2018-06-30 |
226.00 |
$25.09 |
9.01 |
| 2018-03-31 |
220.00 |
$22.52 |
9.77 |
| 2017-12-31 |
202.00 |
$20.71 |
9.76 |
| 2017-09-30 |
290.80 |
$23.68 |
12.28 |
| 2017-06-30 |
294.00 |
$26.90 |
10.93 |
| 2017-03-31 |
420.00 |
$29.76 |
14.11 |
| 2016-12-31 |
560.00 |
$51.25 |
10.93 |
| 2016-09-30 |
825.00 |
$270.48 |
3.05 |
| 2016-06-30 |
765.00 |
$369.62 |
2.07 |
| 2016-03-31 |
865.00 |
$697.58 |
1.24 |
| 2015-12-31 |
14700.00 |
$922.83 |
15.93 |
| 2015-09-30 |
16070.00 |
$970.04 |
16.57 |
| 2015-06-30 |
15500.00 |
$1,524.95 |
10.16 |
| 2015-03-31 |
17250.00 |
$1,721.17 |
10.02 |
| 2014-12-31 |
32500.00 |
$1,586.00 |
20.49 |
| 2014-09-30 |
41250.00 |
$1,513.92 |
27.25 |
| 2014-06-30 |
56250.00 |
$1,121.25 |
50.17 |
| 2014-03-31 |
69375.00 |
$596.96 |
116.21 |
| 2013-12-31 |
101250.00 |
$485.87 |
208.39 |
| 2013-09-30 |
119250.00 |
$288.07 |
413.96 |
| 2013-06-30 |
56250.00 |
$21.81 |
2578.71 |
| 2013-03-31 |
53250.00 |
$17.90 |
2975.37 |
| 2012-12-31 |
45000.00 |
$15.46 |
2910.39 |
| 2012-09-30 |
28125.00 |
$24.12 |
1166.15 |
| 2012-06-30 |
24375.00 |
$24.63 |
989.57 |
| 2012-03-31 |
18750.00 |
$22.87 |
819.80 |
| 2011-12-31 |
105000.00 |
$19.39 |
5413.87 |
| 2011-09-30 |
131250.00 |
$4.29 |
30575.93 |
| 2011-06-30 |
33750.00 |
$0.53 |
63281.25 |
| 2011-03-31 |
36000.00 |
0 |
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.010B |
$0.002B |
|
Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS.
|
